{"ticker": "EXCA", "overview": {"cik": "1411685", "ticker": "VTGN", "name": "Vistagen Therapeutics, Inc.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0000947871-26-000804", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001193125-26-352371", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "Quarterly report", "accession": "0001628280-26-057116", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001831942-26-000032", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-14", "title": "Material event", "accession": "0001628280-26-056953", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "Material event", "accession": "0001628280-26-054341", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-05", "title": "Material event", "accession": "0001628280-26-053304", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-31", "title": "Form DEFA14A", "accession": "0001628280-26-051406", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-07-31", "title": "Proxy statement", "accession": "0001628280-26-051404", "price_sensitive": false}, {"form": "4", "date": "2026-07-31", "title": "Insider transaction", "accession": "0001911501-26-000006", "price_sensitive": false}, {"form": "3", "date": "2026-07-31", "title": "Initial insider holdings", "accession": "0001911501-26-000004", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-31", "title": "Material event", "accession": "0001628280-26-051251", "price_sensitive": true}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001924908-26-000007", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001794362-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001412071-26-000006", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-30", "title": "Material event", "accession": "0001628280-26-046143", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-17", "title": "Material event", "accession": "0001628280-26-043989", "price_sensitive": true}, {"form": "10-K", "date": "2026-06-15", "title": "Annual report", "accession": "0001628280-26-043271", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-15", "title": "Material event", "accession": "0001628280-26-043232", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-09", "title": "Material event", "accession": "0001628280-26-041962", "price_sensitive": true}, {"form": "4", "date": "2026-05-19", "title": "Insider transaction", "accession": "0002132062-26-000004", "price_sensitive": false}, {"form": "3", "date": "2026-05-19", "title": "Initial insider holdings", "accession": "0002132062-26-000003", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-19", "title": "Material event", "accession": "0001628280-26-036492", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-05-15", "title": "Form SCHEDULE 13G/A", "accession": "0001193125-26-226886", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001628280-26-033883", "price_sensitive": true}]}, "description": "", "exchange": null, "stats": {"buy_n": 0, "buy_sum": 0, "sell_n": 1, "sell_sum": 0, "net": 0, "insiders": 1, "first_date": "2011-05-09", "last_date": "2011-05-09"}, "metrics": {"ticker": "EXCA", "has_prices": false}, "trades": [{"id": "0001415889-11-000426", "src": "INSIDERS", "ticker": "EXCA", "cik": "1411685", "company": "Vistagen Therapeutics, Inc.", "company_raw": "Excaliber Enterprises, Ltd.", "who": "Shawn Singh", "who_key": "Singh Shawn", "role": "CHIEF EXECUTIVE OFFICER, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 266304.5, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on EXCA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1411685/000141588911000426/0001415889-11-000426-index.htm", "trade_date": "2011-05-11", "timestamp": "2011-05-11", "mins": 8142645}, {"id": "0001415889-11-000428", "src": "INSIDERS", "ticker": "EXCA", "cik": "1411685", "company": "Vistagen Therapeutics, Inc.", "company_raw": "Excaliber Enterprises, Ltd.", "who": "H. Ralph Snodgrass", "who_key": "SNODGRASS H. RALPH", "role": "PRES./CHIEF SCIENTIFIC OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 1908956.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on EXCA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1411685/000141588911000428/0001415889-11-000428-index.htm", "trade_date": "2011-05-11", "timestamp": "2011-05-11", "mins": 8142645}, {"id": "0001415889-11-000430", "src": "INSIDERS", "ticker": "EXCA", "cik": "1411685", "company": "Vistagen Therapeutics, Inc.", "company_raw": "Excaliber Enterprises, Ltd.", "who": "A. Franklin Rice", "who_key": "RICE A. FRANKLIN", "role": "CHIEF FINANCIAL OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 803323.5, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on EXCA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1411685/000141588911000430/0001415889-11-000430-index.htm", "trade_date": "2011-05-11", "timestamp": "2011-05-11", "mins": 8142645}, {"id": "0001415889-11-000432", "src": "INSIDERS", "ticker": "EXCA", "cik": "1411685", "company": "Vistagen Therapeutics, Inc.", "company_raw": "Excaliber Enterprises, Ltd.", "who": "Jon S. Saxe", "who_key": "SAXE JON S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 60739.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on EXCA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1411685/000141588911000432/0001415889-11-000432-index.htm", "trade_date": "2011-05-11", "timestamp": "2011-05-11", "mins": 8142645}, {"id": "0001415889-11-000456", "src": "INSIDERS", "ticker": "EXCA", "cik": "1411685", "company": "Vistagen Therapeutics, Inc.", "company_raw": "Excaliber Enterprises, Ltd.", "who": "Stephanie Jones", "who_key": "JONES STEPHANIE", "role": "PRESIDENT, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "President sells $0 of EXCA", "source_url": "https://www.sec.gov/Archives/edgar/data/1411685/000141588911000456/0001415889-11-000456-index.htm", "trade_date": "2011-05-09", "timestamp": "2011-05-09", "mins": 8145525}], "recent_buys": [], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Stephanie Jones", "who_key": "JONES STEPHANIE", "role": "PRESIDENT, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 0, "net": 0, "trades": 1, "top_score": 0, "lean": "buying", "history": [{"action": "SELL", "amount": 0, "date": "2011-05-09", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1411685/000141588911000456/0001415889-11-000456-index.htm"}], "latest": {"action": "SELL", "amount": 0, "date": "2011-05-09", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1411685/000141588911000456/0001415889-11-000456-index.htm"}}], "activity": [], "announcements": [{"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0000947871-26-000804", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001193125-26-352371", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "Quarterly report", "accession": "0001628280-26-057116", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001831942-26-000032", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-14", "title": "Material event", "accession": "0001628280-26-056953", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "Material event", "accession": "0001628280-26-054341", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-05", "title": "Material event", "accession": "0001628280-26-053304", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-31", "title": "Form DEFA14A", "accession": "0001628280-26-051406", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-07-31", "title": "Proxy statement", "accession": "0001628280-26-051404", "price_sensitive": false}, {"form": "4", "date": "2026-07-31", "title": "Insider transaction", "accession": "0001911501-26-000006", "price_sensitive": false}, {"form": "3", "date": "2026-07-31", "title": "Initial insider holdings", "accession": "0001911501-26-000004", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-31", "title": "Material event", "accession": "0001628280-26-051251", "price_sensitive": true}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001924908-26-000007", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001794362-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001412071-26-000006", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-30", "title": "Material event", "accession": "0001628280-26-046143", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-17", "title": "Material event", "accession": "0001628280-26-043989", "price_sensitive": true}, {"form": "10-K", "date": "2026-06-15", "title": "Annual report", "accession": "0001628280-26-043271", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-15", "title": "Material event", "accession": "0001628280-26-043232", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-09", "title": "Material event", "accession": "0001628280-26-041962", "price_sensitive": true}, {"form": "4", "date": "2026-05-19", "title": "Insider transaction", "accession": "0002132062-26-000004", "price_sensitive": false}, {"form": "3", "date": "2026-05-19", "title": "Initial insider holdings", "accession": "0002132062-26-000003", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-19", "title": "Material event", "accession": "0001628280-26-036492", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-05-15", "title": "Form SCHEDULE 13G/A", "accession": "0001193125-26-226886", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001628280-26-033883", "price_sensitive": true}], "performance": {"ticker": "EXCA", "has_prices": false, "summary": null, "buys": []}, "price_series": [], "refreshing": true}